American Neuropsychiatric Association (ANPA)
TitleADAPT: Alzheimer's Disease Anti-inflammatory Prevention Trial
InvestigatorDr. John Breitner
Other InvestigatorsDr. Robert C. Green, Dr. Sanford Auerbach
Brief AbstractThe goal of ADAPT is to determine if non-steroidal anti-inflammatory medication will prevent or delay the onset of AD.
Inclusion/Exclusion CriteriaIndividuals may be eligible to participate if they have a living or deceased family member (biological parent or sibling)who has or had serious age-related memory loss suggestive of Alzheimer's disease (AD). Also, participants must be 70 years of age or older.
Opportunities for CollaborationPlease contact study coordinator.

American Neuropsychiatric Association
• Menninger Clinic • 12301 Main St. • Houston, TX 77035 • 713.275.5777